HOME >> BIOLOGY >> NEWS
Nanotechnology: consumers must be convinced benefits outweigh risks

Washington -- There is no doubt that nanotechnology has the potential to make the world a better place, said Project on Emerging Nanotechnologies Chief Scientist Andrew Maynard. But if consumers and other stakeholders are not convinced that the benefits outweigh the risks, many applications will not see the light of day. Likewise, if the benefits are unclear and the risks uncertain, the products of nanotechnology will be a hard sell.

Dr. Maynards remark is in his presentation today before a public meeting of the Presidents Council of Advisors on Science and Technology (PCAST). He spoke as part of a panel devoted to addressing and managing the potential health, environmental and safety risks of nanotechnology.

Nanotechnology is turning our world upside down...It also is shaking up our understanding of what makes something harmful and how we deal with that, according to Maynard. He described the current U.S. policy toward managing the possible health and safety risks of nanotechnologies as approaching 21st century technologies with a 20th century mindset.

Maynard called on the federal government to develop a goal-driven risk research strategy to provide decision-makersincluding regulators, industry and consumerswith the scientific information they need to help develop and use nanotechnologies as safely as possible. He suggested an international approach to this challenge based on a set of strategic research questions developed by thirteen top scientists last year which were published in the journal Nature.

The paper, Safe handling of nanotechnology (Maynard et al., Nature, vol. 44, 16 November 2006), was praised as a landmark in the history of nanotechnology research by the then chair Sherwood Boehlert (R-NY) and ranking member Bart Gordon (D-TN) of the U.S. Congresss House Science Committee. In a statement about the papers findings, the Congressmen said they both had made it clear that they felt the Administration was mov
'"/>

Contact: Alex Parlini
alex.parlini@wilsoncenter.org
202-691-4282
Project on Emerging Nanotechnologies
25-Jun-2007


Page: 1 2

Related biology news :

1. Green Nanotechnology: Its Easier Than You Think
2. Nanotechnology: The story behind the headlines
3. Leanest teens are biggest energy users and consumers
4. Research on salmonella in the poultry industry may result in safer food for consumers
5. Dietary Guidelines Alliance offers tools to help consumers understand new nutrition guidance
6. Researchers convinced satellites are helpful in tracking epidemics
7. Cardio exercise benefits in male vs. female hearts
8. Researchers probe risks, benefits of folic acid fortification
9. Research ends debate over benefits of butterfly defenses
10. Penn study finds ICD devices offer heart patients life-saving benefits
11. Wilson Center and Pew Charitable Trusts expand efforts to examine risks/benefits of nanotechnology

Post Your Comments:
(Date:7/27/2015)... July 27, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Huawei has selected the ... for its stylish smartwatch. Huawei chose the state-of-the-art ... low power and highly responsive human interface qualities ... designers also required a classic round watch face ...
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/23/2015)... Inc. (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended June 30, 2015.  Revenue for ... of 33% compared to $6.8 million in the same quarter ... was $0.3 million, or $0.01 per diluted share, which compared ... same period a year ago.  Lower revenue ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6
(Date:7/28/2015)... A n ew UK ... and commercialising innovative medicines to transform patient quality of life ... management team; blue chip investor ... Group Ltd ("Mereo"), a recently-formed speciality biopharmaceutical company, announces that ... from blue chip institutional investors and simultaneously acquired a portfolio ...
(Date:7/28/2015)... ... July 29, 2015 , ... Strong Animals™ announced today that research ... operation and presented at the ADSA-ASAS Joint Annual Meeting held July 12-16 in Orlando, ... cows and increased milk fat content. Also, feed containing Stay Strong™ for Dairy Cows ...
(Date:7/28/2015)... ... July 29, 2015 , ... The new Xsample 530 sample changer for vials ... wide range of liquid viscosities – from less than 12,000 mPas (internal air) up to ... , What immediately catches the eye about Xsample 530 is its removable magazine, which ...
(Date:7/28/2015)... 28, 2015  PDL BioPharma, Inc. (PDL, or the ... Company will release its second quarter 2015 financial results ... August 5, 2015, after market close. PDL,s management will ... 4:30 p.m. Eastern Time to discuss the financial results. ... available via the webcast link on the PDL website. ...
Breaking Biology Technology:Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 2Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 3Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 4Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 5Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 6Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 7Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 8Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 9Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 10Mereo BioPharma Announces Formal Launch of Company; Raises $119m (c.£76.5m) and Acquires Innovative Mid-Stage Clinical Product Portfolio From Leading Pharmaceutical Company 11Strong Animals™ Announces South Dakota State University Research Demonstrates Stay Strong™ for Dairy Cows Improves Performance and Feed Stability 2New Moves in Automatic Sample Handling: Introducing Xsample 530 2PDL BioPharma to Announce Second Quarter 2015 Financial Results on August 5, 2015 2
Cached News: